Literature DB >> 8421320

Tissue distribution, excretion, and urinary metabolites of dichloroacetic acid in the male Fischer 344 rat.

E L Lin1, J K Mattox, F B Daniel.   

Abstract

The disposition of dichloroacetic acid (DCA) was investigated in Fischer 344 rats over the 48 h after oral gavage of 282 mg/kg of 1- or 2-[14C]-DCA (1-DCA or 2-DCA) and 28.2 mg/kg of 2-DCA. DCA was absorbed quickly, and the major route of disposition was through exhalation of carbon dioxide and elimination in the urine. The dispositions of 1- and 2-DCA at 282 mg/kg were similar. With 2-DCA, the disposition differed with dose in that the percentage of the dose expired as carbon dioxide decreased from 34.4% (28.2 mg/kg) to 25.0% (282 mg/kg), while the percentage of the radioactivity excreted in the urine increased from 12.7 to 35.2%. This percentage increase in the urinary excretion was mostly attributable to the presence of unmetabolized DCA, which comprised more than 20% at the higher dose and less than 1% at the lower dose. The major urinary metabolites were glycolic acid, glyoxylic acid, and oxalic acid. DCA and its metabolites accumulated in the tissues and were eliminated slowly. After 48 h, 36.4%, 26.2%, and 20.8% of the dose was retained in the tissues of rats administered 28.2 and 282 mg/kg of 2-DCA and 282 mg/kg of 1-DCA, respectively. Of the organs examined, the liver (4.9-7.9% of dose) and muscle (4.5-9.9%) contained the most radioactivity, followed by skin (3.3-4.5%), blood (1.4-2.6%), and intestines (1.0-1.7%). One metabolite, glyoxylic acid, which is mutagenic, might be responsible for or contribute to the carcinogenicity of DCA.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8421320     DOI: 10.1080/15287399309531697

Source DB:  PubMed          Journal:  J Toxicol Environ Health        ISSN: 0098-4108


  8 in total

1.  Mitochondrion as a novel site of dichloroacetate biotransformation by glutathione transferase zeta 1.

Authors:  Wenjun Li; Margaret O James; Sarah C McKenzie; Nigel A Calcutt; Chen Liu; Peter W Stacpoole
Journal:  J Pharmacol Exp Ther       Date:  2010-09-30       Impact factor: 4.030

2.  A Mechanism-Based Pharmacokinetic Enzyme Turnover Model for Dichloroacetic Acid Autoinhibition in Rats.

Authors:  Yu Jiang; Gary Milavetz; Margaret O James; Guohua An
Journal:  J Pharm Sci       Date:  2017-02-03       Impact factor: 3.534

3.  Toxicity and carcinogenicity of the water disinfection byproduct, dibromoacetic acid, in rats and mice.

Authors:  Ronald L Melnick; Abraham Nyska; Paul M Foster; Joseph H Roycroft; Grace E Kissling
Journal:  Toxicology       Date:  2006-12-08       Impact factor: 4.221

4.  Glutathione transferase zeta catalyses the oxygenation of the carcinogen dichloroacetic acid to glyoxylic acid.

Authors:  Z Tong; P G Board; M W Anders
Journal:  Biochem J       Date:  1998-04-15       Impact factor: 3.857

5.  Physiologically based pharmacokinetic modeling of dibromoacetic acid in F344 rats.

Authors:  Jessica L Matthews; Irvin R Schultz; Michael R Easterling; Ronald L Melnick
Journal:  Toxicol Appl Pharmacol       Date:  2010-01-04       Impact factor: 4.219

Review 6.  The Importance of Gender-Related Anticancer Research on Mitochondrial Regulator Sodium Dichloroacetate in Preclinical Studies In Vivo.

Authors:  Donatas Stakišaitis; Milda Juknevičienė; Eligija Damanskienė; Angelija Valančiūtė; Ingrida Balnytė; Marta Maria Alonso
Journal:  Cancers (Basel)       Date:  2019-08-20       Impact factor: 6.639

7.  Exposure Characterization of Haloacetic Acids in Humans for Exposure and Risk Assessment Applications: An Exploratory Study.

Authors:  Shahid Parvez; Jeffrey L Ashby; Susana Y Kimura; Susan D Richardson
Journal:  Int J Environ Res Public Health       Date:  2019-02-06       Impact factor: 3.390

8.  Low-dose pharmacokinetics and oral bioavailability of dichloroacetate in naive and GST-zeta-depleted rats.

Authors:  Shakil A Saghir; Irvin R Schultz
Journal:  Environ Health Perspect       Date:  2002-08       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.